flurbiprofen has been researched along with betadex in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 13 (52.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eissens, AC; Franssen, EJ; Frijlink, HW; Lerk, CF; Meijer, DK; Oosting, R | 1 |
| Imai, T; Otagiri, M; Saitô, H; Uekama, K | 1 |
| Hirayama, F; Imai, T; Irie, T; Maeda, T; Otagiri, M; Uekama, K | 1 |
| Imai, T; Otagiri, M; Uekama, K | 1 |
| Lin, BC; Zhu, XF | 1 |
| Govindarajan, R; Nagarsenker, MS | 2 |
| Machida, Y; Muraoka, A; Tokumura, T | 2 |
| Cirri, M; Corti, G; Maestrelli, F; Mura, P; Rangoni, C | 1 |
| Granero, GG; Longhi, MR; Maitre, MM | 1 |
| Fanali, S; Rocco, A | 1 |
| Chong, S | 1 |
| Balakrishnan, P; Choi, HG; Han, MJ; Joe, JH; Kim, JO; Li, DX; Oh, DH; Park, SM; Seo, Y; Yan, YD; Yong, CS | 1 |
| Arima, H; Hirayama, F; Iohara, D; Ishiguro, T; Morishita, E; Motoyama, K; Uekama, K; Wada, K | 1 |
| Calpena, AC; Egea, MA; Espina, M; García, ML; Vega, E | 1 |
| Holm, R; Jørgensen, EB; Larsen, KL; Lumholdt, LR | 1 |
| Fillet, M; Servais, AC | 1 |
| Li, W; Luo, Q; Zhang, X; Zhao, X | 1 |
| Calpena, AC; Egea, MA; Espina, M; García, ML; Garduño-Ramírez, ML; Sánchez, E; Vega, E | 1 |
| Gaš, B; Riesová, M; Svobodová, J; Tošner, Z; Ušelová, K; Zusková, I | 1 |
| Dubský, P; Gaš, B; Müllerová, L | 1 |
| Gu, J; Guo, T; Guo, Z; Li, H; Shao, Q; Sun, L; Wang, C; Wu, L; Yin, X; York, P; Zhang, J | 1 |
| Alexander, BD; Ghori, MU; Kaialy, W; Rudrangi, SR; Snowden, MJ; Trivedi, V | 1 |
| Cheng, BC; Gai, XM; Li, JY; Pan, H; Pan, WS; Wang, HB; Yang, FF; Yang, XG | 1 |
25 other study(ies) available for flurbiprofen and betadex
| Article | Year |
|---|---|
The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Blood Proteins; Cyclodextrins; Flurbiprofen; Injections, Intravenous; Male; Naproxen; Rats; Rats, Inbred Strains; Tissue Distribution | 1991 |
Inclusion mode of flurbiprofen with beta-cyclodextrin and heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin, and improvements of some pharmaceutical properties of flurbiprofen by complexation.
Topics: Animals; beta-Cyclodextrins; Chemistry, Pharmaceutical; Cyclodextrins; Flurbiprofen; Intestinal Absorption; Propionates; Rabbits | 1988 |
Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
Topics: beta-Cyclodextrins; Chemistry, Pharmaceutical; Cyclodextrins; Dextrins; Differential Thermal Analysis; Drug Stability; Flurbiprofen; Kinetics; Propionates; Solubility; Spectrophotometry, Infrared; Starch; Suppositories; Temperature; Thermodynamics; X-Ray Diffraction | 1985 |
Enhanced oral bioavailability of antiinflammatory drug flurbiprofen in rabbits by tri-O-methyl-beta-cyclodextrin complexation.
Topics: Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Cyclodextrins; Dextrins; Flurbiprofen; Propionates; Rabbits; Solubility; Starch | 1982 |
[Chiral separation of naproxen and flurbiprofen by capillary electrophoresis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Cyclodextrins; Electrophoresis, Capillary; Flurbiprofen; Naproxen; Stereoisomerism | 2000 |
Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Chemistry, Pharmaceutical; Cyclodextrins; Excipients; Flurbiprofen; Magnetic Resonance Spectroscopy; Povidone; Solubility; Solvents | 2004 |
Evaluation of the bioavailability of flurbiprofen and its beta-cyclodextrin inclusion complex in four different doses upon oral administration to rats.
Topics: Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flurbiprofen; Male; Rats; Rats, Sprague-Dawley | 2004 |
Formulation studies and in vivo evaluation of a flurbiprofen-hydroxypropyl beta-cyclodextrin system.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Evaluation, Preclinical; Edema; Flurbiprofen; Humans; Male; Rats; Rats, Wistar | 2005 |
Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Carriers; Excipients; Flurbiprofen; Microscopy; Powder Diffraction; Solubility; Spectroscopy, Fourier Transform Infrared; Tablets; X-Ray Diffraction | 2005 |
Ternary complexes of flurbiprofen with HP-beta-CD and ethanolamines characterization and transdermal delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Ethanolamines; Flurbiprofen; Humans; Skin Absorption; Solubility; Spectroscopy, Fourier Transform Infrared | 2007 |
Enantiomeric separation of acidic compounds by nano-liquid chromatography with methylated-beta-cyclodextrin as a mobile phase additive.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzoxazoles; beta-Cyclodextrins; Carbazoles; Chromatography, Liquid; Flurbiprofen; Hydrogen-Ion Concentration; Indoprofen; Ketoprofen; Methylation; Molecular Structure; Nanotechnology; Naproxen; Propionates; Stereoisomerism; Suprofen; Time Factors | 2009 |
Improvement of oral bioavailability of flurbiprofen from flurbiprofen/beta-cyclodextrin inclusion complex by action of cinnarizine.
Topics: Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Cinnarizine; Drug Combinations; Drug Delivery Systems; Drug Interactions; Flurbiprofen; Male; Rats; Rats, Sprague-Dawley | 2009 |
Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Biological Availability; Excipients; Flurbiprofen; Humans; Micelles; Pharmaceutical Solutions; Solubility; Tissue Distribution | 2010 |
Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Biological Availability; Drug Carriers; Flurbiprofen; Kinetics; Male; Micelles; Polysorbates; Powders; Rats; Rats, Sprague-Dawley; Solubility; Solutions; Surface-Active Agents | 2010 |
Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Drug Carriers; Excipients; Flurbiprofen; Hemolysis; Hydrophobic and Hydrophilic Interactions; Male; Phenylacetates; Rabbits; Solubility; Structure-Activity Relationship | 2011 |
Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Ophthalmic; Analysis of Variance; Animals; beta-Cyclodextrins; Cornea; Cryoprotective Agents; Drug Stability; Epithelium, Corneal; Flurbiprofen; Freeze Drying; Gamma Rays; Lactic Acid; Male; Nanospheres; Particle Size; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits | 2012 |
In vitro investigations of α-amylase mediated hydrolysis of cyclodextrins in the presence of ibuprofen, flurbiprofen, or benzo[a]pyrene.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; alpha-Amylases; alpha-Cyclodextrins; Animals; Benzo(a)pyrene; beta-Cyclodextrins; Drug Stability; Flurbiprofen; gamma-Cyclodextrins; Hydrolysis; Ibuprofen; Kinetics; Pancreas; Solubility; Solutions; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Swine | 2012 |
Enantioseparations in nonaqueous capillary electrophoresis using charged cyclodextrins.
Topics: Alprenolol; beta-Cyclodextrins; Bupranolol; Electrophoresis, Capillary; Flurbiprofen; Propionates; Stereoisomerism; Suprofen; Temperature; Terbutaline; Ultraviolet Rays | 2013 |
Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallography, X-Ray; Cyanoacrylates; Drug Carriers; Emulsions; Flurbiprofen; Male; Nanoparticles; Particle Size; Powder Diffraction; Rats; Rats, Wistar; Solvents; Surface Properties | 2014 |
Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Female; Flurbiprofen; Humans; Inflammation; Lactic Acid; Nanospheres; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Skin; Skin Absorption | 2013 |
Determination of thermodynamic values of acidic dissociation constants and complexation constants of profens and their utilization for optimization of separation conditions by Simul 5 Complex.
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Computer Simulation; Electrophoresis, Capillary; Flurbiprofen; Hydrogen-Ion Concentration; Ibuprofen; Ketoprofen; Magnetic Resonance Spectroscopy; Naproxen; Osmolar Concentration; Software; Thermodynamics; Viscosity | 2014 |
Generalized model of electromigration with 1:1 (analyte:selector) complexation stoichiometry: part II. Application to dual systems and experimental verification.
Topics: beta-Cyclodextrins; Electrophoresis, Capillary; Flurbiprofen; Hydrogen-Ion Concentration; Models, Theoretical; Stereoisomerism | 2015 |
Prediction of Rate Constant for Supramolecular Systems with Multiconfigurations.
Topics: beta-Cyclodextrins; Flurbiprofen; Hydrogen-Ion Concentration; Ibuprofen; Kinetics; Ligands; Macromolecular Substances; Pyronine; Thermodynamics | 2016 |
Solid-state flurbiprofen and methyl-β-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process.
Topics: beta-Cyclodextrins; Flurbiprofen; Molecular Docking Simulation; Powder Diffraction; Solubility; Solvents | 2016 |
A pH-independent instantaneous release of flurbiprofen: a study of the preparation of complexes, their characterization and in vitro/in vivo evaluation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Liberation; Flurbiprofen; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Microscopy, Electron, Scanning; Rats; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |